For the Second Consecutive Year, 2019 was the Year of Healthcare IPOs.

Article by

Article Date

Category

Related posts

Browse all articles

We are Delighted that our Portfolio Company, miRecule, Entered into a Strategic Collaboration with Sanofi with Potential Future Milestone Payments of nearly $400 Million

We are happy to jointly lead Genalyte’s last financing with Verily (Alphabet subsidiary) with the participation of Redmile Group, Provenio Capital, HBM Healthcare Investments, Khosla Ventures, Samsara BioCapital, and The Invus Group.